Development and Application of a Nanoradiopharmaceutical Based on the Monoclonal Antibody Bevacizumab for Endometriosis: Comparison Between Normal and Nanoparticulate Monoclonal Antibody as Imaging Radiopharmaceutical

In: Advanced Science, Engineering and Medicine · 2017 · vol. 9(10) , pp. 824–828 · doi:10.1166/asem.2017.2074 · W2761879085
article OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
unpaywall
last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0 · commercial use OK